This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.
Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is correcting two documents that provided notice of the approval of new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs). FDA is correcting the chemical entities listed in the subject lines of both documents that were transposed during document preparation. The address for one of the drug sponsors is also being corrected. These corrections are being made to improve the accuracy of the Federal Register.Start Further Info
FOR FURTHER INFORMATION CONTACT:
George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-4567, e-mail: email@example.com.End Further Info End Preamble Start Supplemental Information
1. On page 40984, in the first column, in the title, “Clindamycin” is corrected to read “Bacitracin; Lasalocid; Narasin; Roxarsone”.
1. On page 41161, in the third column, in the title, “Bacitracin; Lasalocid; Narasin; Roxarsone” is corrected to read “Clindamycin”; and
2. On page 41161, in the third column, in the second paragraph of the SUPPLEMENTARY INFORMATION section, the address for Delmarva Laboratories, Inc., is corrected to read “1500 Huguenot Rd., suite 106, Midlothian, VA 23113”.Start Signature
Dated: September 15, 2003.
Deputy Director, Center for Veterinary Medicine.
[FR Doc. 03-24158 Filed 9-22-03; 8:45 am]
BILLING CODE 4160-01-S